ArticleCancer science2018

New metformin derivative HL156A prevents oral cancer progression by inhibiting the insulin-like growth factor/AKT/mammalian target of rapamycin pathways.

Thuy Giang Lam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.